
taigen biotechnology company
TaiGen, HEC ChangJiang To Jointly Develop Chronic Hep C Treatments
The new company will develop, manufacture and commercialize treatments for chronic Hepatitis C virus infection in the Greater China region.

TaiGen’s Nemonoxacin Receives US FDA Fast Track Designation
TaiGen Biotech's nemonoxacin has received fast track designation and Qualified Infectious Disease Product status by the US FDA.